Trials / Unknown
UnknownNCT02457585
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis. This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11
Detailed description
Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis. This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11 patients with active takayasu's arteritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | remicade (anti tumor necrosis factor inhibitor) | single arm:remicade treatment group |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2017-08-01
- Completion
- 2018-04-01
- First posted
- 2015-05-29
- Last updated
- 2017-05-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02457585. Inclusion in this directory is not an endorsement.